药学服务对老年慢性阻塞性肺病患者临床疗效的影响

发布时间：2018-12-15 13:36

【摘要】：目的:探究临床药师开展药学服务对老年慢性阻塞性肺疾病(COPD)患者临床疗效的影响。方法:将2012年7—12月在四川大学华西医院呼吸科诊断为COPD的96例患者随机分为2组,实验组50例,对照组46例。实验组的患者入院时和出院时分别评估CAT评分和mMRC分级,住院期间对其开展药学服务,协作医生制定治疗方案,监护患者用药全过程,防治药物不良反应和药物相互作用等工作;对照组不施加任何干预措施。6个月后,通过统计2组患者出院CAT评分和mMRC分级的差异来评估2组患者的疗效。结果:分析结果显示,实验组出院CAT评分为(20.60±5.37),对照组(23.20±5.07)(P0.05);实验组出院mMRC分级为(2.54±0.54),对照组(2.83±0.64)(P0.05);均有显著差异。结论:临床药师开展药学服务对改善老年COPD患者病情起了积极作用。
[Abstract]:Objective: to investigate the effect of pharmacological care on elderly patients with chronic obstructive pulmonary disease (COPD). Methods: 96 patients diagnosed as COPD in Department of Respiratory, West China Hospital of Sichuan University from July to December 2012 were randomly divided into two groups: the experimental group (n = 50) and the control group (n = 46). The patients in the experimental group were evaluated CAT score and mMRC grade on admission and discharge respectively. During hospitalization, the patients were given pharmaceutical care, doctors cooperated with each other to formulate the treatment plan, and the whole process of drug use was monitored. Prevention and treatment of adverse drug reactions and drug interactions; After 6 months, the difference of CAT score and mMRC grade between the two groups was calculated to evaluate the curative effect of the two groups. Results: the CAT score was (20.60 卤5.37) and (23.20 卤5.07) in the experimental group and (23.20 卤5.07) in the control group (P0.05), and the mMRC score in the experimental group was (2.54 卤0.54), that in the control group was (2.83 卤0.64) (P0.05). There were significant differences between the two groups. Conclusion: clinical pharmacists' pharmaceutical care plays a positive role in improving the condition of elderly patients with COPD.
【作者单位】：四川大学华西医院药剂科;四川大学华西药学院;
【分类号】：R563.9

【参考文献】